`

OBIGEN PHARMA

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About OBIGEN PHARMA

What does Obigen pharma do?+

Established in 2020, OBIGEN Pharma, a subsidiary of OBI Pharma, is the first biotech startup in Taiwan specializing in the research, development, production, and manufacturing of Botulinum toxin. Their type A botulinum toxin, OBI-858, originates from an API plant adhering to the PIC/s GMP standards in the Zhubei Biomedical Science Park and a high-security sterile drug product plant in the Tainan Science Park. Guided by diligent efforts, OBIGEN develops and produces stable quality products, contributing to advancing the entire medical industry. With a dedicated focus on innovation and vitality, OBIGEN actively forges international partnerships to globally launch the exceptional Taiwan...

What is Obigen pharma's industry? +

Obigen pharma operates in the Biotechnology research industry.

What is Obigen pharma's revenue? +

Obigen pharma's revenue is 11m - 100m

What is Obigen pharma's company size? +

Obigen pharma has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.